Ayala Pharmaceuticals, Inc..
Follow Ayala Pharmaceuticals, Inc.Ayala Pharmaceuticals, Inc. is a clinical-stage oncology company primarily focused on developing and commercializing small molecule therapeutics for people living with rare tumors and aggressive cancers.[1]
Deals on Carrywatch
Every deal that names Ayala Pharmaceuticals, Inc., and its role in each.
Immunome, Inc. / Ayala Pharmaceuticals, Inc.
Immunome purchases Ayala Pharmaceuticals assets in completed sale
See deal detailsAyala Pharmaceuticals, Inc. / Biosight, Ltd.
Ayala Pharmaceuticals completes merger with Biosight
See deal detailsAdvaxis, Inc. / Ayala Pharmaceuticals, Inc.
Advaxis, Inc. agrees to buy Ayala Pharmaceuticals, Inc.
See deal detailsDeal Web
Ayala Pharmaceuticals, Inc. and 0 firms it shares a posted deal with, and the path to any other firm.
Financials
5 fiscal years of figures as Ayala Pharmaceuticals, Inc. reported them.
Comparable companies
10 companies and transactions named as comparable to Ayala Pharmaceuticals, Inc..
News
Loading headlines.
Sources
As of 24 Oct 2026.
- 01Ayala Pharmaceuticals Announces Closing of Merger with Biosight
Company disclosure · Researched 24 Oct 2026
- 02Form 8-K Current Report
Company disclosure · Researched 24 Oct 2026
Deal posts naming Ayala Pharmaceuticals, Inc.:
- P01
- P02
- P03